Abstract
Cardiac intervention remains controversial in patients with trisomy 13 and 18 and little is known about factors that may affect outcomes. The goal of this study was to evaluate preoperative factors and surgical approach with respect to outcomes in these patients. Patients with congenital heart disease and trisomy 13 or 18 presenting to our institution from 2004 through 2015 were retrospectively reviewed. Patients were grouped into complete intervention, palliated intervention, and non-intervention. Pre-intervention variables, timing and type of intervention, post-intervention outcomes, and survival were recorded and comparisons were made between the groups. Of 34 patients, 18 cardiac interventions were performed. Complete repair was performed in 11(61%) and palliation in 7(39%). Median age for complete repair was 9.2 vs. 1.7 months in palliated patients (p < 0.001) and palliated patients were smaller (median 2.5 vs. 5.2 kg, p < 0.001). All patients who underwent complete repair survived to discharge compared to only 57% of patients that were palliated (p = 0.04). Palliated patients had longer intubation and time to discharge (p < 0.05). Survival at last follow-up was greater in the complete repair group compared with palliated patients and non-intervention patients (72, 14, and 18%, p = 0.009) with a longer median length of survival in the complete repair group (p = 0.002). In our group of trisomy 13 and 18 patients, those able to undergo complete repair had improved outcomes. Patients undergoing complete repair were older and bigger; this suggests that delaying intervention and optimizing the likelihood of complete repair may be beneficial.
Similar content being viewed by others
References
Embleton ND, Wyllie JP, Wright MJ, Burn J, Hunter S (1996) Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed 75(1):F38–F41
Rasmussen SA, Wong LY, Yang Q, Kay KM, Friedman JM (2003) Population based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111(4 Pt 1):777–784
Van Dyke DC, Allen M (1990) Clinical management considerations in long-term survivors with trisomy 18. Pediatrics 85(5):753–759
Root S, Carey JC (1994) Survival in trisomy 18. Am J Med Genet 49(2):170–174
Smith A, Field B, Learoyd BM (1989) Trisomy 18 at age 21 years. Am J Med Genet 34(3):338–339
Baty BJ, Blackburn BL, Carey JC (1994) Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 49(2):175–188
Kelly M, Robinson BW, Moore JW (2002) Trisomy 18 in a 20-year-old woman. Am J Med Genet 112(4):397–399
Petek E, Pertl B, Tschernigg M, Bauer M, Mayr J, Wasner K, Kroisel PM (2003) Characterization of a 19-year-old ‘long-term survivor’ with Edwards syndrome. Genet Couns 14(2):239–244
Shanske AL (2006) Trisomy 18 in a second 20-year old woman. Am J Med Genet A 140(9):966–967
Bruns DA (2010) Noeonatal experiences of newborns with full trisomy 18. Adv Neonatal Care 10(1):25–31
Janvier A, Farlow B, Wilfond BS (2012) The experience of families with children with trisomy 13 and 18 in social networks. Pediatrics 130(2):293–298
Lorenz JM, Hardart GE (2014) Evolving medical and surgical management of infants with trisomy 18. Curr Opin in Pediatr 26(2):169–176
Nelson KE, Rosella LC, Mahant S, Guttmann A (2016) Survival and surgical interventions for children with trisomy 13 and 18. JAMA 316(4):420–428
Matsuoka R, Misugi K, Goto A, Gilbert EF, Ando M (1983) Congenital heart anomalies in the trisomy 18 syndrome, with reference to congenital polyvalvular disease. Am J Med Genet 14(4):657–668
Musewe NN, Alexander DJ, Teshima I, Smallhorn JF, Freedom RM (1990) Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18. J Am Coll Cardiol 15(3):673–677
Nakai Y, Asano M, Nomura N, Matsumae H, Mishima A (2016) Effectiveness of cardiac surgery in patients with trisomy 18: a single-institutional experience. Cardiol Young 26(7):1391–1396
Maeda J, Yamagishi H, Furutani Y, Kamisago M, Waragai T, Oana S, Kajino H, Matsuura H, Mori K, Matsuoka R, Nakanishi R (2011) The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet A 155A(11):2641–2646
Kaneko Y, Kobayashi J, Achiwa I, Yoda H, Tsuchiya K, Nakajima Y, Endo K, Sato H, Kawakami T (2009) Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 30(6):729–734
Costello J, Weiderhold A, Louis C, Shaughness C, Peer S, Zurakowski D, Jonas R, Nath D (2015) A contemporary, single-institutional experience of surgical versus expectant management of congenital heart disease in trisomy 13 and 18 patients. Pediatr Cardiol 36(5):987–992
Graham EM, Bradley SM, Shirali GS, Hills CB, Atz AM (2004) Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 93(6):801–803
Bruns DA, Martinez A (2016) An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18. Am J Med Genet A 170A(2):337–343
Janvier A, Farlow B, Barrington K (2016) Cardiac surgery for children with trisomies 13 and 18: where are we now? Semin Perinatol 40(4):254–260
Van Praagh S, Truman T, Firpo A, Bano-Rodrigo A, Fried R, McManus B, Engle MA, Van Praagh R (1989) Cardiac malformations in trisomy 18: a study of 41 postmortem cases. J Am Coll Cardiol 13(7):1586–1597
Acknowledgments
The authors would like to thank Paula Buchanan, PhD for her assistance with the statistical methods and analysis for the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have indicated that they have no potential conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Peterson, R., Calamur, N., Fiore, A. et al. Factors Influencing Outcomes After Cardiac Intervention in Infants with Trisomy 13 and 18. Pediatr Cardiol 39, 140–147 (2018). https://doi.org/10.1007/s00246-017-1738-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-017-1738-y